|
1
|
Marino BLB, Souza LR, Sousa KPA, Ferreira
JV, Padilha EC, Silva CHTP, Taft CA and Hage-Melim LIS: Parkinson's
disease: A Review from the Pathophysiology to Diagnosis, New
Perspectives for Pharmacological Treatment. Mini Rev Med Chem: Nov
3, 2019 (Epub ahead of print). doi:
10.2174/1389557519666191104110908.
|
|
2
|
de Lau LM and Breteler MM: Epidemiology of
Parkinson's disease. Lancet Neurol. 5:525–535. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fasano M, Bergamasco B and Lopiano L:
Modifications of the iron-neuromelanin system in Parkinson's
disease. J Neurochem. 96:909–916. 2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Griffiths PD and Crossman AR: Distribution
of iron in the basal ganglia and neocortex in postmortem tissue in
Parkinson's disease and Alzheimer's disease. Dementia. 4:61–65.
1993.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dexter DT, Carayon A, Javoy-Agid F, Agid
Y, Wells FR, Daniel SE, Lees AJ, Jenner P and Marsden CD:
Alterations in the levels of iron, ferritin and other trace metals
in Parkinson's disease and other neurodegenerative diseases
affecting the basal ganglia. Brain. 114:1953–1975. 1991.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dusek P, Jankovic J and Le W: Iron
dysregulation in movement disorders. Neurobiol Dis. 46:1–18.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rhodes SL, Buchanan DD, Ahmed I, Taylor
KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD,
Rotter JI and Ritz B: Pooled analysis of iron-related genes in
Parkinson's disease: Association with transferrin. Neurobiol Dis.
62:172–178. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sian-Hulsmann J, Mandel S, Youdim MB and
Riederer P: The relevance of iron in the pathogenesis of
Parkinson's disease. J Neurochem. 118:939–957. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Andersen JK: Oxidative stress in
neurodegeneration: Cause or consequence? Nat Med. 10
(Suppl):S18–S25. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tysnes OB and Storstein A: Epidemiology of
Parkinson's disease. J Neural Transm (Vienna). 124:901–905.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hardy PA, Gash D, Yokel R, Andersen A, Ai
Y and Zhang Z: Correlation of R2 with total iron concentration in
the brains of rhesus monkeys. J Magn Reson Imaging. 21:118–127.
2005.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Aquino D, Bizzi A, Grisoli M, Garavaglia
B, Bruzzone MG, Nardocci N, Savoiardo M and Chiapparini L:
Age-related iron deposition in the basal ganglia: Quantitative
analysis in healthy subjects. Radiology. 252:165–172.
2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hallgren B and Sourander P: The effect of
age on the non-haemin iron in the human brain. J Neurochem.
3:41–51. 1958.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ropele S, Wattjes MP, Langkammer C,
Kilsdonk ID, Graaf WL, Frederiksen JL, Fuglø D, Yiannakas M,
Wheeler-Kingshott CA, Enzinger C, et al: Multicenter R2*
mapping in the healthy brain. Magn Reson Med. 71:1103–1107.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Du G, Lewis MM, Styner M, Shaffer ML, Sen
S, Yang QX and Huang X: Combined R2* and diffusion
tensor imaging changes in the substantia nigra in Parkinson's
disease. Mov Disord. 26:1627–1632. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Martin WR, Wieler M and Gee M: Midbrain
iron content in early Parkinson disease: A potential biomarker of
disease status. Neurology. 70:1411–1417. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kennan RP, Zhong J and Gore JC:
Intravascular susceptibility contrast mechanisms in tissues. Magn
Reson Med. 31:9–21. 1994.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fernandez-Seara MA and Wehrli FW:
Postprocessing technique to correct for background gradients in
image-based R*(2) measurements. Magn Reson Med.
44:358–366. 2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu C, Li W, Tong KA, Yeom KW and
Kuzminski S: Susceptibility-weighted imaging and quantitative
susceptibility mapping in the brain. J Magn Reson Imaging.
42:23–41. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li W, Wu B and Liu C: Quantitative
susceptibility mapping of human brain reflects spatial variation in
tissue composition. NeuroImage. 55:1645–1656. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu T, Spincemaille P, de Rochefort L,
Kressler B and Wang Y: Calculation of susceptibility through
multiple orientation sampling (COSMOS): A method for conditioning
the inverse problem from measured magnetic field map to
susceptibility source image in MRI. Magn Reson Med. 61:196–204.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Langkammer C, Schweser F, Krebs N,
Deistung A, Goessler W, Scheurer E, Sommer K, Reishofer G, Yen K,
Fazekas F, et al: Quantitative susceptibility mapping (QSM) as a
means to measure brain iron? A post mortem validation study.
NeuroImage. 62:1593–1599. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu T, Eskreis-Winkler S, Schweitzer AD,
Chen W, Kaplitt MG, Tsiouris AJ and Wang Y: Improved subthalamic
nucleus depiction with quantitative susceptibility mapping.
Radiology. 269:216–223. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Langkammer C, Pirpamer L, Seiler S,
Deistung A, Schweser F, Franthal S, Homayoon N, Katschnig-Winter P,
Koegl-Wallner M, Pendl T, et al: Quantitative Susceptibility
Mapping in Parkinson's Disease. PLoS One.
11(e0162460)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Murakami Y, Kakeda S, Watanabe K, Ueda I,
Ogasawara A, Moriya J, Ide S, Futatsuya K, Sato T, Okada K, et al:
Usefulness of quantitative susceptibility mapping for the diagnosis
of Parkinson disease. AJNR Am J Neuroradiol. 36:1102–1108.
2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
He N, Ling H, Ding B, Huang J, Zhang Y,
Zhang Z, Liu C, Chen K and Yan F: Region-specific disturbed iron
distribution in early idiopathic Parkinson's disease measured by
quantitative susceptibility mapping. Hum Brain Mapp. 36:4407–4420.
2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hughes AJ, Daniel SE, Kilford L and Lees
AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's
disease: A clinico-pathological study of 100 cases. J Neurol
Neurosurg Psychiatry. 55:181–184. 1992.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hoehn MM and Yahr MD: Parkinsonism: Onset,
progression, and mortality. 1967. Neurology. 57 (10 Suppl
3):S11–S26. 2001.PubMed/NCBI
|
|
29
|
Wu B, Li W, Guidon A and Liu C: Whole
brain susceptibility mapping using compressed sensing. Magn Reson
Med. 67:137–147. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Schweser F, Deistung A, Lehr BW and
Reichenbach JR: Quantitative imaging of intrinsic magnetic tissue
properties using MRI signal phase: An approach to in vivo brain
iron metabolism? NeuroImage. 54:2789–2807. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li W, Wang N, Yu F, Han H, Cao W, Romero
R, Tantiwongkosi B, Duong TQ and Liu C: A method for estimating and
removing streaking artifacts in quantitative susceptibility
mapping. NeuroImage. 108:111–122. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li W, Langkammer C, Chou YH, Petrovic K,
Schmidt R, Song AW, Madden DJ, Ropele S and Liu C: Association
between increased magnetic susceptibility of deep gray matter
nuclei and decreased motor function in healthy adults. NeuroImage.
105:45–52. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li W, Wu B, Batrachenko A, Bancroft-Wu V,
Morey RA, Shashi V, Langkammer C, De Bellis MD, Ropele S, Song AW
and Liu C: Differential developmental trajectories of magnetic
susceptibility in human brain gray and white matter over the
lifespan. Hum Brain Mapp. 35:2698–2713. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lewis MM, Du G, Kidacki M, Patel N,
Shaffer ML, Mailman RB and Huang X: Higher iron in the red nucleus
marks Parkinson's dyskinesia. Neurobiol Aging. 34:1497–1503.
2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zywicke HA, van Gelderen P, Connor JR,
Burdo JR, Garrick MD, Dolan KG, Frank JA and Bulte JW: Microscopic
R2* mapping of reduced brain iron in the Belgrade rat.
Ann Neurol. 52:102–105. 2002.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu C, Wei H, Gong NJ, Cronin M, Dibb R
and Decker K: Quantitative susceptibility mapping: Contrast
mechanisms and clinical applications. Tomography. 1:3–17.
2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Griffiths PD, Dobson BR, Jones GR and
Clarke DT: Iron in the basal ganglia in Parkinson's disease. An in
vitro study using extended X-ray absorption fine structure and
cryo-electron microscopy. Brain. 122:667–673. 1999.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Meineke J, Rauscher A, Marques JP, Bilgic
B and Langkammer C: Quantitative Susceptibility Mapping in
Parkinson's Disease. Magnetic Resonance Med.
11(e0162460)2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Double KL, Gerlach M, Youdim MB and
Riederer P: Impaired iron homeostasis in Parkinson's disease. J
Neural Transm Suppl. S37–S58. 2000.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gerlach M, Double KL, Ben-Shachar D, Zecca
L, Youdim MB and Riederer P: Neuromelanin and its interaction with
iron as a potential risk factor for dopaminergic neurodegeneration
underlying Parkinson's disease. Neurotox Res. 5:35–44.
2003.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zecca L, Youdim MB, Riederer P, Connor JR
and Crichton RR: Iron, brain ageing and neurodegenerative
disorders. Nat Rev Neurosci. 5:863–873. 2004.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gerlach M, Double KL, Youdim MB and
Riederer P: Potential sources of increased iron in the substantia
nigra of parkinsonian patients. J Neural Transm Suppl. S133–S142.
2006.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Drayer B, Burger P, Darwin R, Riederer S,
Herfkens R and Johnson GA: MRI of brain iron. AJR Am J Roentgenol.
147:103–110. 1986.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Habas C and Cabanis EA: Cortical
projection to the human red nucleus: Complementary results with
probabilistic tractography at 3 T. Neuroradiology. 49:777–784.
2007.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lapresle J and Hamida MB: The
dentato-olivary pathway. Somatotopic relationship between the
dentate nucleus and the contralateral inferior olive. Arch Neurol.
22:135–143. 1970.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Bird TD and Shaw CM: Progressive myoclonus
and epilepsy with dentatorubral degeneration: A clinicopathological
study of the Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry.
41:140–149. 1978.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Graham JM, Paley MN, Grunewald RA, Hoggard
N and Griffiths PD: Brain iron deposition in Parkinson's disease
imaged using the PRIME magnetic resonance sequence. Brain 123 Pt.
12:2423–2431. 2000.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wood JC, Enriquez C, Ghugre N, Tyzka JM,
Carson S, Nelson MD and Coates TD: MRI R2 and R2*
mapping accurately estimates hepatic iron concentration in
transfusion-dependent thalassemia and sickle cell disease patients.
Blood. 106:1460–1465. 2005.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Homayoon N, Pirpamer L, Franthal S,
Katschnig-Winter P, Kögl M, Seiler S, Wenzel K, Hofer E,
Deutschmann H, Fazekas F, et al: Nigral iron deposition in common
tremor disorders. Mov Disord. 34:129–132. 2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Barbosa JH, Santos AC, Tumas V, Liu M,
Zheng W, Haacke EM and Salmon CE: Quantifying brain iron deposition
in patients with Parkinson's disease using quantitative
susceptibility mapping, R2 and R2. Magn Reson Imaging. 33:559–565.
2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Lotfipour AK, Wharton S, Schwarz ST, Gontu
V, Schäfer A, Peters AM, Bowtell RW, Auer DP, Gowland PA and Bajaj
NP: High resolution magnetic susceptibility mapping of the
substantia nigra in Parkinson's disease. J Magn Reson Imaging.
35:48–55. 2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Eapen M, Zald DH, Gatenby JC, Ding Z and
Gore JC: Using high-resolution MR imaging at 7T to evaluate the
anatomy of the midbrain dopaminergic system. AJNR Am J Neuroradiol.
32:688–694. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Schafer A, Forstmann BU, Neumann J,
Wharton S, Mietke A, Bowtell R and Turner R: Direct visualization
of the subthalamic nucleus and its iron distribution using
high-resolution susceptibility mapping. Hum Brain Mapp.
33:2831–2842. 2012.PubMed/NCBI View Article : Google Scholar
|
